Search Results

There are 8585 results for: content related to: Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy—A prospective case series

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  3. Lamivudine salts with improved solubilities

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 6, June 2012, Pages: 2143–2154, Felipe T. Martins, Rudy Bonfilio, Magali B. De Araújo and Javier Ellena

    Version of Record online : 14 MAR 2012, DOI: 10.1002/jps.23117

  4. Viral Hepatitis

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Mario Rizzetto, Fabien Zoulim, Pages: 819–956, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch9a

  5. Lamivudine treatment of chronic hepatitis B

    Reviews in Medical Virology

    Volume 8, Issue 3, July/September 1998, Pages: 153–159, Geoffrey Dusheiko

    Version of Record online : 4 MAY 1999, DOI: 10.1002/(SICI)1099-1654(199807/09)8:3<153::AID-RMV228>3.0.CO;2-Y

  6. Management of chronic hepatitis B virus infection: a new era of disease control

    Internal Medicine Journal

    Volume 36, Issue 2, February 2006, Pages: 100–113, G. C. Farrell and N. C. Teoh

    Version of Record online : 10 FEB 2006, DOI: 10.1111/j.1445-5994.2006.01027.x

  7. You have free access to this content
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 844–853, Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

    Version of Record online : 27 DEC 2007, DOI: 10.1002/hep.22106

  8. Developmental Pharmacokinetic Changes of Lamivudine in Infants and Children

    The Journal of Clinical Pharmacology

    Volume 52, Issue 12, December 2012, Pages: 1824–1832, Dr Adriana H. Tremoulet, Dr Mina Nikanjam, Dr Tim R. Cressey, Dr Kulkanya Chokephaibulkit, Dr Ross McKinney, Dr Mark Mirochnick and Dr Edmund V. Capparelli

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011426563

  9. You have free access to this content
    Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB

    Hepatology

    Volume 29, Issue 3, March 1999, Pages: 889–896, Nicolaos C. Tassopoulos, Riccardo Volpes, Giuseppe Pastore, Jenny Heathcote, Maria Buti, Robert D. Goldin, Sasha Hawley, Judy Barber, Lynn Condreay and D. Fraser Gray

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510290321

  10. You have free access to this content
    Covariate effects and population pharmacokinetics of lamivudine in HIV-infected children

    British Journal of Clinical Pharmacology

    Volume 77, Issue 5, May 2014, Pages: 861–872, Chiara Piana, Wei Zhao, Kimberly Adkison, David Burger, Evelyne Jacqz-Aigrain, Meindert Danhof and Oscar Della Pasqua

    Version of Record online : 22 APR 2014, DOI: 10.1111/bcp.12247

  11. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  12. Lamivudine/Zidovudine as a Combined Formulation Tablet: Bioequivalence Compared with Lamivudine and Zidovudine Administered Concurrently and the Effect of Food on Absorption

    The Journal of Clinical Pharmacology

    Volume 39, Issue 6, June 1999, Pages: 593–605, Dr. Katy H. P. Moore, Ms. Shuching Shaw, Dr. Aziz L. Laurent, Ms. Peggy Lloyd, Mr. Benjamin Duncan, Mr. David M. Morris, Mr. Michael J. O'Mara and Dr. Gary E. Pakes

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912709922008209

  13. You have free access to this content
    Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 3, March 2010, Pages: 583–590, Li-Jie Sun, Jian-Wu Yu, Yong-Hua Zhao, Peng Kang and Shu-Chen Li

    Version of Record online : 24 NOV 2009, DOI: 10.1111/j.1440-1746.2009.06089.x

  14. Chronic Hepatitis B Viral Infection

    Textbook of Gastroenterology

    Robert G. Gish, Stephen Locarnini, Pages: 2112–2138, 2009

    Published Online : 17 FEB 2009, DOI: 10.1002/9781444303254.ch81

  15. Tenofovir for the Treatment of Hepatitis B Virus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 10, October 2009, Pages: 1212–1227, Dr. Alice M. Jenh, Dr. Chloe L. Thio and Dr. Paul A. Pham

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.10.1212

  16. Chronic Hepatitis B: Current and Future Treatment Options

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 6, June 2002, Pages: 721–737, Anastasia Rivkina and Sergey Rybalov

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.22.9.721.34058

  17. Lamivudine for hepatitis B in clinical practice

    Journal of Medical Virology

    Volume 61, Issue 3, July 2000, Pages: 386–391, Eugene R. Schiff

    Version of Record online : 6 JUN 2000, DOI: 10.1002/1096-9071(200007)61:3<386::AID-JMV18>3.0.CO;2-X

  18. You have free access to this content
    A model-based approach for the evaluation of once daily dosing of lamivudine in HIV-infected children

    British Journal of Clinical Pharmacology

    Volume 77, Issue 5, May 2014, Pages: 852–860, Chiara Piana, Wei Zhao, Kimberly Adkison, David Burger, Evelyne Jacqz-Aigrain, Meindert Danhof and Oscar Della Pasqua

    Version of Record online : 22 APR 2014, DOI: 10.1111/bcp.12246

  19. Confirmation of the chromosome damaging effects of lamivudine in in vitro human peripheral blood lymphocytes

    Environmental and Molecular Mutagenesis

    Volume 49, Issue 4, May 2008, Pages: 328–333, Süleyman Bayram and Mehmet Topaktaş

    Version of Record online : 25 MAR 2008, DOI: 10.1002/em.20393

  20. Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole

    Clinical Pharmacology & Therapeutics

    Volume 59, Issue 5, May 1996, Pages: 550–558, Katy H. P. Moore, Geoffrey J. Yuen, Ralph H. Raasch, Joseph J. Eron, David Martin, Patricia K. Mydlow and Elizabeth K. Hussey

    Version of Record online : 20 MAY 1996, DOI: 10.1016/S0009-9236(96)90183-6